Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-TCR Summit Europe 2021 | CAR-TCR Europe highlights: synthetic biology & the autologous vs allogeneic debate

Dalip Sethi, PhD, Terumo BCT, Lakewood, CO, describes his highlights from the CAR-TCR Summit Europe 2021 including how exciting advances seen in the field of synthetic biology could lead to significant developments in the field in the coming years. He also discusses the ongoing debate between autologous and allogeneic approaches and how he expects the use of these technologies will evolve and lead to benefits in patients suffering from a wide range of cancer types. This interview took place during the CAR-TCR Summit Europe 2021.


Dalip Sethi is an employee of Terumo Blood and Cell Technologies, Inc. (Lakewood, CO, USA).